Paraoxonase 1 (PON1) modulates the toxicity of mixed organophosphorus compounds

Toxicology and Applied Pharmacology

Volumn 236, Issue 2, 2009, Pages 142-153

  Jansen, Karen L ^a   Cole, Toby B ^a   Park, Sarah S ^a   Furlong, Clement E ^a   Costa, Lucio G ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Chlorpyrifos; Diazinon; Insecticide mixtures; Malathion; Organophosphate; Paraoxonase; Parathion; PON1

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; CARBOXYLESTERASE; CHLORPYRIFOS; CHLORPYRIFOS OXON; DIAZOXON; MALAOXON; ORGANOPHOSPHORUS COMPOUND; PARAOXON; TRI ORTHO CRESYL PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALYSIS; CONTROLLED STUDY; DETOXIFICATION; ENZYME ASSAY; FEMALE; GENOTYPE; HYDROLYSIS; MALE; MOUSE; NONHUMAN; TOXICITY TESTING; WILD TYPE;

ANIMALS; ARYLDIALKYLPHOSPHATASE; CARBOXYLIC ESTER HYDROLASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; FEMALE; GENOTYPE; HUMANS; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; ORGANOPHOSPHORUS COMPOUNDS; PESTICIDES;

MUS; MUS MUSCULUS;

EID: 62549166186     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.02.001     Document Type: Article

References (68)

1. Abernathy C.O., and Casida J.E. Pyrethroid insecticides: esterase cleavage in relation to selective toxicity. Science 179 (1973) 1235-1236
2. Adkins S., Gan K.N., Mody M., and La Du B.N. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. Am. J. Hum. Genet. 53 (1993) 598-608
3. Aldridge W.N. Tricresyl phosphates and cholinesterase. Biochem. J. 56 (1954) 185-189
4. Buratti F.M., and Testai E. Malathion detoxication by human hepatic carboxylesterase and its inhibition by isomalathion and other pesticides. J. Biochem. Mol. Toxicol. 19 6 (2005) 406-414
5. Casida J.E., Eto M., and Baron R.L. Biological activity of a tri-o-cresyl phosphate metabolite. Nature 191 (1961) 1396-1397
6. Casida J.E., Baron R.L., Eto M., and Engel J.L. Potentiation and neurotoxicity induced by certain organophosphates. Biochem. Pharmacol. 12 (1963) 73-83
7. Chambers H.W., Brown B., and Chambers J.E. Noncatalytic detoxication of six organophosphorus compounds by rat liver homogenates. Pestic. Biochem. Physiol. 36 (1990) 308-315
8. Chambers J.E., Ma T., Boone J.S., and Chambers H.W. Role of detoxication pathways in acute toxicity levels of phosphorothionate insecticides in the rat. Life Sci. 54 18 (1994) 1357-1364
9. Chen P.R., Tucker W.P., and Dauterman W.C. Structure of biologically produced malathion monoacid. J. Agr. Food Chem. 17 (1969) 86-90
10. Choi J., Hodgson E., and Rose R.L. Inhibition of transpermethrin hydrolysis in human liver fractions by chloropyrifos oxon and carbaryl. Drug Metab. Drug Inter. 20 (2004) 233-246
11. Cohen S.D., and Murphy S.D. Malathion potentiation and inhibition of hydrolysis of various carboxylic esters by triorthotolyl phosphate (TOTP) in mice. Biochem. Pharmacol. 20 (1971) 575-587
12. Cohen S.D., and Murphy S.D. Carboxylesterase inhibition as an indicator of malathion potentiation in mice. J. Pharmacol. Exp. Ther. 176 3 (1971) 733-742
13. Cohen S.D., Callaghan J.E., and Murphy S.D. Investigation of multiple mechanisms for potentiation of malaoxon's anticholinesterase action by triorthotolyl phosphate. Proc. Soc. Exp. Biol. Med. 141 3 (1972) 906-910
14. Cole T.B., Jampsa R.L., Walter B.J., Arndt T.A., Richter R.J., Shih D.M., Tward A., Lusis A.J., Jack R.M., Costa L.G., and Furlong C.E. Expression of human paraoxonase (PON1) during development. Pharmacogenetics 13 (2003) 357-364
15. Cole T.B., Walter B.J., Shih D.M., Tward A.D., Lusis A.J., Timchalk C., Richter R.J., and Costa L.G. Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism. Pharmacogenet. Genomics 15 (2005) 589-598
16. Cook J.W., Blake J.R., and Williams M.W. J. Assess. Office Agr. Chem. 40 (1957) 664
17. Cook J.W., and Yip G. Malathionase. II. Identity of a malathion metabolite. J. Assess. Office Agr. Chem. 41 (1958) 407-411
18. Costa L.G. Current issues in organophosphate toxicology. Clin. Chim. Acta. 366 (2006) 1-13
19. Costa L.G., McDonald B.E., Murphy S.D., Omenn G.S., Richter R.J., Motulsky A.G., and Furlong C.E. Serum paraoxonase and its influence onparaoxon and chlorpyrifos-oxon toxicity in rats. Toxicol. Appl. Pharmacol. 103 (1990) 66-76
20. Costa L.G., Li W.-F., Richter R.J., Shih D.M., Lusis A.J., and Furlong C.E. The role of paraoxonase (PON1) in the detoxication of organophosphates and its human polymorphism. Chem. Biol. Interact. 119-120 (1999) 429-438
21. Davies H., Richter R.J., Kiefer M., Broomfield C., Sowalla J., and Furlong C.E. The human serum paraoxonase polymorphism is reversed with diazinon, soman and sarin. Nat. Genet. 14 (1996) 334-336
22. DuBois K.P. Potentiation of toxicity of insecticidal organophosphates. Arch. Industr. Health 18 (1958) 488-496
23. DuBois K.P. Combined effects of pesticides. Canad. Med. Assoc. J. 100 (1969) 173-179
24. DuBois K.P., Doull J., Deroin J., and Cumming O.R. Studies on the toxicity and mechanism of action of some new insecticidal thionophosphates. Arch. Ind. Hyg. Occup. Med. 8 (1953) 350-358
25. Ellman G.L., Courtney K.D., Andres V.J., and Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7 (1961) 88-95
26. Furlong C.E. Genetic variability in the cytochrome P450-paraoxonase 1 (PON1) pathway for detoxication of organophosphorus compounds. J. Biochem. Mol. Toxicol. 21 4 (2007) 197-205
27. Furlong C.E. The Bert La Du Memorial Lecture: Paraoxonases: an historical perspective. In: Mackness B., Mackness M., Aviram M., and Paragh G. (Eds). The Paraoxonases: Their Role In Disease, Development And Xenobiotic Metabolism (2008), Springer, Dordrecht, The Netherlands 3-31
28. Furlong C.E., Richter R.J., Seidel S.L., Costa L.G., and Motulsky A.G. Spectrophotometric assays fro the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arlyesterase. Anal. Biochem. 180 (1989) 242-247
29. Furlong C.E., Costa L.G., Hassett C., Richter R.J., Sundstrom J.A., Adler D.A., Disteche C.M., Omiecinski C.J., Chapline C., Crabb J.W., et al. Human and rabbit paraoxonases: purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxification. Chem. Biol. Interact. 87 (1993) 35-48
30. Furlong C.E., Holland N., Richter R.J., Bradman A., Ho A., and Eskenazi B. PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity. Pharmacogenet. Genomics 16 (2006) 183-190
31. Gaughan L.C., Engel J.L., and Casida J.E. Pesticide interactions: effects of organophosphorus pesticides on the metabolism, toxicity, and persistence of selected pyrethroid insecticides. Pestic. Biochem. Physiol. 14 (1980) 81-85
32. Godin S.J., Crow J.A., Scollon E.J., Hughes M.F., DeVito M.J., and Ross M.K. Identification of rat and human cytochrome P450 isoforms and a rat serum esterase that metabolize the pyrethroid insecticides Deltamethrin and Esfenvalerate. Drug Metab. Dispos. 35 (2007) 1664-1671
33. Hassett C., Richter R.J., Humbert R., Chapline C., Crabb J.W., Omiecinski C.J., and Furlong C.E. Characterization of cDNA clones encoding rabbit and human serum paraoxonase: The mature protein retains its signal sequence. Biochemistry 30 (1991) 10141-10149
34. Hosokawa M., Endo T., Fujisawa M., Hara S., Iwata N., Sato Y., and Satoh T. Interindividual variation in carboxylesterase levels in human liver microsomes. Drug Metab. Dispos. 23 (1995) 1022-1027
35. Humbert R., Adler D.A., Disteche C.M., Hassett C., Omiecinski C.J., and Furlong C.E. The molecular basis of the human serum paraoxonase activity polymorphism. Nat. Genet. 3 (1993) 73-76
36. Jarvik G.P., Jampsa R., Richter R.J., Carlson C.S., Rieder M.J., Nickerson D.A., and Furlong C.E. Novel paraoxonase (PON1) nonsense and missense mutations predicted by functional genomic assay of PON1 status. Pharmacogenetics 13 5 (2003) 291-295
37. Li W.F., Costa L.G., and Furlong C.E. Serum paraoxonase status: a major factor in determining resistance to organophosphates. J. Toxicol. Environ. Health 40 (1993) 337-346
38. Li W.F., Furlong C.E., and Costa L.G. Paraoxonase protects against chlorpyrifos toxicity in mice. Toxicol. Lett. 76 (1995) 219-226
39. Li W.F., Costa L.G., Richter R.J., Hagen T., Shih D.M., Tward A., Lusis A.J., and Furlong C.E. Catalytic efficiency determines the in vivo efficacy of PON1 for detoxifying organophosphates. Pharmacogenetics 10 (2000) 767-799
40. Li B., Sedlacek M., Manoharan I., Boopathy R., Duysen E.G., Masson P., and Lockridge O. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Biochem. Pharmacol. 70 (2005) 1673-1684
41. Main A.R. The role of A-esterase in the acute toxicity of paraoxon, TEPP and parathion. Can. J. Biochem. Physiol. 34 (1956) 197-216
42. Main A.R., and Dauterman W.C. Kinetic for the inhibition of carboxylesterase by malaoxon. Can. J. Biochem. 45 (1967) 757-771
43. March R.B., Fukuto T.R., Metcalf R.L., and Moxon M.G. Fate of P32 labelled malathion in the laying hen, white mouse and American cockroach. J. Econ. Entomol. 49 (1956) 185-195
44. Moser V.C., Casey M., Hamm A., Carter Jr. W.H., Simmons J.E., and Gennings C. Neurotoxicological and statistical analyses of a mixture of five organophosphorus pesticides using a ray design. Toxicol. Sci. 86 1 (2005) 101-115
45. Moser V.C., Simmons J.E., and Gennings C. Neurotoxicological interactions of a five-pesticide mixture in preweanling rats. Toxicol. Sci. 92 1 (2006) 235-245
46. Munger J.S., Shi G.P., Mark E.A., Chin D.T., Gerard C., and Chapman H.A. A serine esterase released by human alveolar macrophages is closely related to liver microsomal carboxylesterases. J. Biol. Chem. 266 28 (1991) 18832-18838
47. Murphy S.D., and DuBois K.P. Quantitative measurement of inhibition of the enzymatic detoxification of malathion by EPN (ethyl p-nitrophenyl thionobenzene phosphate). Proc. Soc. Exp. Biol. Med. 96 (1957) 813-818
48. Murphy S.D., Anderson R.L., and DuBois K.P. Potentiation of toxicity of malathion by triorthotolyl phosphate. Proc. Soc. Exp. Biol. Med. 100 (1959) 483-487
49. O'Brien R.D. Properties and metabolism in the cockroach and mouse of malathion and malaoxon. J. Econ. Entomol. 50 (1957) 159-1164
50. Pond A.L., Chambers H.W., Coyne C.P., and Chambers J.E. Purification of two rat hepatic proteins with A-esterase activity toward chlorpyrifos-oxon and paraoxon. J. Pharmacol. Exp. Ther. 286 (1998) 1404-1411
51. Ramakrishna N., and Ramachandran B.V. Malathion A and B esterases of mouse liver-III: In vivo effect of parathion and related PNP-containing insecticides on esterase inhibition and potentiation of malathion toxicity. Biochem. Pharmacol. 27 16 (1978) 2049-2054
52. Richter R.J., and Furlong C.E. Determination of paraoxonase (PON1) status requires more than genotyping. Pharmacogenetics 9 6 (1999) 745-753
53. Richter R.J., Jarvik G.P., and Furlong C.E. Determination of paraoxonase 1 status without the use of toxic organophosphate substrates. Circ. Cardiovasc. Genet. 1 (2008) 147-152
54. Richter R.J., Jarvik G.P., and Furlong C.E. Paraoxonase 1 (PON1) Status and Substrate hydrolysis. Toxicol. Appl. Pharmacol. 235 (2009) 1-9
55. Satoh T., and Hosokawa M. Structure, function and regulation of carboxylesterases. Chem. Biol. Interact. 162 3 (2006) 195-211
56. Seume F.W., and O'Brien R.D. Potentiation of toxicity to insects and mice of phosphorothionates containing carboxyester and carboxyamide groups. Toxicol. Appl. Pharmacol. 2 (1960) 495-503
57. Shih D.M., Gu L., Xia Y.R., Navab M., Li W.F., Hama S., Castellani L.W., Furlong C.E., Costa L.G., Fogelman A.M., and Lusis A.J. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394 (1998) 284-287
58. Su M.Q., Kinoshita F.K., Frawley J.P., and DuBois K.P. Comparative inhibition of aliesterases and cholinesterase in rats fed eighteen organophosphorus insecticides. Toxicol. Appl. Pharmacol. 20 (1971) 241-249
59. Tang J., and Chambers J.E. Detoxication of paraoxon by rat liver homogenate and serum carboxylesterases and A-esterases. J. Biochem. Mol. Toxicol. 13 (1999) 261-268
60. Tang J., Cao Y., Rose R.L., Brimfield A.A., Dai D., Goldstein J.A., and Hodgson E. Metabolism of chlorpyrifos by human cytochrome P450 isoforms and human, mouse, and rat liver microsomes. Drug Metab. Dispos. 29 9 (2001) 1201-1204
61. Timchalk C., Poet T.S., Hinman M.N., Busby A.L., and Kousba A.A. Pharmacokinetic and pharmacodynamic interaction for a binary mixture of chlorpyrifos and diazinon in the rat. Toxicol. Appl. Pharmacol. 205 (2005) 31-42
62. U.S. Environmental Protection Agency. Policy on a common mechanism of action: the organophosphate pesticides. Fed. Regist. 64 24 (1999) 5795-5799
63. U.S. Environmental Protection Agency, 2002. Organophosphate pesticides: revised OP cumulative risk assessment. www.epa.gov/pesticides/cumulative/rra-op/2002.
64. U.S. Environmental Protection Agency, 2006. Organophosphorus Cumulative Risk Assessment- 2006 Update. Technical Executive Summary. US EPA Office of Pesticide Programs. www.epa.gov/oppsrrd1/cumulative/2006-op/.
65. Verschoyle R.D., Reiner E., Bailey E., and Aldridge W.N. Dimethylphosphorothioates. Reaction with malathion and effect on malathion toxicity. Arch. Toxicol. 49 3-4 (1982) 293-301
66. Wheelock C.E., Eder K.J., Werner I., Huang H., Jones P.D., Brammell B.F., Elskus A.A., and Hammock B.D. Individual variability in esterase acticity and CYP1A levels in Chinook salmon (Oncorhynchus tshawytscha) exposed to esfenvalerate and chlorpyrifos. Aquat. Toxicol. 74 (2005) 172-192
67. Williams F.M., Mutch E.M., Nicholson E., Wynne E., Wright P., Lambert D., and Rawlins M.D. Human liver and plasma aspirin esterase. J. Pharm. Pharmacol. 41 (1989) 407-409
68. Winder C., and Balouet J.C. The toxicity of commercial jet oils. Environ. Res. 89 (2002) 146-164